Backs FY25 revenue view $3.28B-$3.3B, consensus $3.29B. The company said, “The Company is reaffirming its 2025 financial guidance as updated by its December 2, 2025 press release and reiterated in conjunction with management’s presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026.”
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $22 from $25 at TD Cowen
- Maintaining a Buy on Acadia Healthcare: Valuation Upside and Resilient Medium-Term Growth Despite PLGL-Driven 2025 Reset
- Acadia Healthcare price target lowered to $17 from $19 at RBC Capital
- Acadia Healthcare Reaffirms 2025 Financial Guidance at Conference
- Acadia Healthcare price target lowered to $17 from $22 at Mizuho